Two stocks are quietly flashing green on Friday—and analysts say most retail investors are completely sleeping on them. Big deal. Zydus Lifesciences (NSE: ZYDUSLIFE) and Solar Industries India (NSE: SOLARINDS) have both shown strong buy signals based on technical charts, with potential gains of up to 15% in the near term. Not small. So the Nifty 50 just closed higher for two straight sessions, driven by banking, metal and pharma stocks. So if you've been waiting for a clear market signal, this might be it. But before you do anything, here's exactly what the analysts are saying and why these two names stand out right now.
- Look, Nifty 50 just wrapped up two positive sessions, with banking, metal and pharma leading the way on Friday.
- Analysts are flagging Zydus Lifesciences and Solar Industries India as top buy picks for near-term gains that could hit 15%.
- Zydus Lifesciences (NSE: ZYDUSLIFE) is currently trading around Rs 940, with a TTM P/E of 18.63 — that's well below the sector's 23.87 average.
- The key resistance level for Nifty 50 is 23,800 — it's gotta break that number cleanly for a bigger rally to even begin.
- Zydus posted a hefty net profit of Rs 1,042.10 crore in its last quarter, and mutual funds have been increasing their stake.
- If you hold either of these stocks, you should watch their price action closely around key resistance levels before adding more.
What Is Actually Happening in the Market Right Now
Let's be honest — the Indian stock market has been giving mixed signals for a while now, leaving many investors wondering what's next. True. IT stocks have been weak. And global uncertainty has kept foreign investors nervous. And yet, something definitely shifted this week.
Period.
The Nifty 50 index closed higher for the second straight session on Friday, a subtle but important move that many traders are now watching closely. That doesn't sound like much. Right? But when you look at what's driving that move — banking stocks, metals, and pharma — it tells a much clearer story. These aren't speculative, fly-by-night sectors. Facts. And these are the backbone industries of India. And when they move together, analysts pay attention.
The 23,800 level on Nifty 50 is what every trader is watching right now, and for good reason. Think of it like a ceiling. Wild. The market has been bumping its head against it. If it breaks through cleanly, the next leg of the rally could be strong. And if it doesn't? Expect the market to pull back and test lower levels again. So where does that leave you as an investor? That's exactly the question the next section answers.
And here's why that matters.
Here Is the Full Story on Zydus Lifesciences and Solar Industries
Analysts who track technical charts—the kind of graphs that show price movement patterns—have spotted two very clear buy opportunities this week. Wow. Both stocks are showing what traders call bullish momentum. Think about it. In simple words, the charts are pointing upward and the signals suggest the price has more room to climb.
- Zydus Lifesciences (ZYDUSLIFE) — current price around Rs 940: The stock has been trading between Rs 924 and Rs 943 in the recent session. It's up about 1.78% this year and 2.02% in the last five days. The SMA-20 (a 20-day average price line) is at Rs 911.14 and is in a bullish position — meaning the stock is trading above its own recent average, which is a good sign.
- P/E ratio of 18.63 vs sector average of 23.87: This is a big deal. It means Zydus is cheaper compared to other pharma companies. For every Rs 100 of profit it earns, you're paying only Rs 18.63 in the market. Your neighbor buying a similar pharma stock might be paying Rs 23.87 for the same Rs 100 of profit. That gap matters.
- Net profit of Rs 1,042.10 crore last quarter: Over one thousand crore rupees in profit — in a single quarter. That isn't a struggling company. That's a company in strong financial health.
- Mutual fund holding in Zydus increased: As of March 31, 2026, mutual funds hold 4.88% of the company — and that holding has gone up from the previous quarter. When mutual funds buy more of a stock, it usually means professional money managers believe in its future. Retail investors take note.
- Solar Industries India (SOLARINDS) — strong technical indicators: This company makes explosives and energetic materials for mining, defence and infrastructure. It's been on a consistent uptrend backed by India's growing defence spending and infrastructure push. Technical analysts see bullish continuation patterns forming right now.
- Upside of up to 15% flagged by analysts: Both stocks have been given near-term price targets that suggest gains of up to 15% from current levels. That isn't guaranteed — markets never are — but the technical case is clear and the fundamentals back it up.
Look, the analysts watching these two stocks are pointing to things like RSI levels (a measure of buying and selling momentum), moving average crossovers, and volume spikes—all technical signals suggesting both stocks are building up for a move higher. Key point. In plain words: the conditions that usually come before a price rise are in place right now. That's real.
And it's not just charts. Solar Industries has a real-world story behind it—India's defence budget has been rising sharply, and the government is pushing hard for local manufacturing of ammunition and explosives. That's the truth. Solar Industries is one of the biggest players in that space. So the tailwind is real, not just technical noise. Let that sit.
But not for the reasons you'd expect.
Why These Two Stocks Look Different From the Crowd
Here's the thing people miss. Most stocks move with the market. Big shift. When Nifty goes up, everything goes up a little. When Nifty falls, everything falls. Yep. But once in a while, you find stocks that have their own engine running—stocks where the business itself is doing something special, separate from whatever mood the market is in that day.
Think.
Zydus Lifesciences is one of India's top pharma companies, and its parent, Zydus Group, has a strong track record in the US generic drugs market. And? It's a space where Indian companies have been competing fiercely and winning. Big. With 28 analysts covering the stock and only 5 giving a sell rating, the majority believe this is a stock worth holding or buying. That's an 82% positive coverage ratio. Not bad.
And Solar Industries tells a completely different story but it's just as compelling. Defence, mining, and infrastructure are three areas where the Indian government is pouring money right now. No joke. Solar Industries sits right at the intersection of all three. Unreal. The company's order book has been growing steadily, and margins have held up well even as raw material costs moved around globally.
Now compare this to IT stocks—the sector that was actually dragging the market this week. And now? IT companies are facing headwinds from slowing global tech spending and uncertainty around outsourcing contracts. So while IT drags, pharma and defence-linked stocks like Zydus and Solar are finding their own momentum. That's exactly the kind of rotation that creates short-term trading opportunities. And potentially bigger medium-term gains for patient investors.
Nobody is talking about this enough.
What This Means for You as an Ordinary Investor
For a salaried person in Pune who puts Rs 5,000 to Rs 10,000 a month into stocks through a SIP or direct equity, this kind of analyst recommendation matters. And that's big. But it only matters if you understand what you're actually buying and why. But who really benefits here?
Let's say you buy Zydus Lifesciences at Rs 940 today, hoping to catch the next wave up. If the 15% upside target plays out, that stock would reach around Rs 1,081. Worth it. On an investment of Rs 10,000—roughly the cost of a decent family dinner at a mid-range restaurant in Mumbai—you'd make about Rs 1,500. Not anymore. That's not life-changing money. But stacked across a portfolio, these kinds of moves add up.
But here's the honest part. Technical buy calls work—until they don't. That stings. Markets can reverse quickly, especially when big global events hit overnight. The 23,800 resistance level on Nifty is a real hurdle. And if the market fails to cross it and turns down sharply, even fundamentally good stocks like Zydus and Solar can drop in the short term, simply because panic selling pulls everything down.
Really.
So what should you actually do? If you already hold either stock — stay put and watch the price action. The result? If Nifty breaks cleanly above 23,800 with strong volume, that's your confirmation signal that the rally has legs. If you're thinking of entering fresh—consider buying in two parts, not all at once. Put in half your planned amount now, and keep the other half ready in case the stock dips a little before moving higher. That way you don't miss the move, but you also don't bet everything on a single price point.
For a first-time investor who has never bought individual stocks before, this is also a good moment to observe rather than act. Huge. Watch how these two stocks behave over the next five trading sessions. You'll learn more from watching a real trade play out than from reading ten articles about it. And more.
The numbers don't lie.
What to Watch in the Coming Days
The next few trading sessions are going to be very telling. Here are the specific things to keep your eye on:
First — Nifty 50 and the 23,800 mark. This is the single most important number right now—no question. Read that again. Analysts say a decisive breakout above this level will open the door to further gains across the broader market, which would support both Zydus and Solar Industries moving higher. A failure at 23,800, especially on high selling volume, would be a warning sign to reduce exposure or wait on the sidelines. Period.
Second — FII (foreign investor) activity. Foreign institutional investors have been cautious lately, and that's an understatement. And? If they start buying Indian pharma and defence stocks in bulk again, it would be a strong vote of confidence and could accelerate the upside move in stocks like Zydus. Watch daily FII data on the NSE website—it's public and free. Is this really a surprise?
Third — any fresh earnings or management commentary from either company. Zydus's last quarterly profit was Rs 1,042 crore—strong numbers. Key point. If any new quarterly results or investor presentations come out in the next few weeks that beat or miss expectations, that will move the stock much more than any technical chart signal. And why does this matter right now?
Three scenarios are possible from here. Best case: Nifty clears 23,800, FIIs return as buyers, and both Zydus and Solar hit their 15% targets within three to four weeks. Most likely case: the market moves sideways for a week, tests support once or twice, then gradually moves higher—giving patient investors a reasonable 8-10% gain over a month. Worst case: a global trigger, like a fresh round of currency volatility or an unexpected policy shock, sends Nifty back below 23,500, and even these strong stocks give up 5-7% in the short term before recovering.
The one thing you should do right now? Set a price alert on your trading app for Nifty at 23,800 and for both ZYDUSLIFE and SOLARINDS at your chosen entry price. Don't stare at the screen all day. Set the alert, go about your day, and let the market come to you.
Frequently Asked Questions About Zydus Lifesciences and Solar Industries Stock Tips
Is Zydus Lifesciences a good buy right now in 2026?
Honestly — the signals are looking positive. Zydus is trading around Rs 940 with a P/E of 18.63, which is below the sector average of 23.87, and it just posted a Rs 1,042 crore profit. Analysts see near-term upside.
What is Solar Industries India and why are analysts recommending it?
The thing is, Solar Industries India makes explosives and crucial products for mining, defence, and construction. And with India's defence spending rising sharply and the government pushing for local manufacturing, Solar Industries is in a very strong position. It's a pure 'Make in India' story with strong demand drivers. So analysts are seeing bullish technical patterns forming right now, making it a near-term buy with up to 15% upside potential.
What does the 23,800 Nifty resistance level mean for ordinary investors?
In plain words, 23,800 is a glass ceiling for the Nifty 50. The market keeps hitting that level but hasn't broken through yet. If it breaks above 23,800 with strong buying, it signals a broader rally is probably starting.
How much can I realistically earn if I buy these stocks at current prices?
Good question. If analysts' near-term target of 15% plays out for Zydus from around Rs 940, the price could hit roughly Rs 1,081. So on a Rs 10,000 investment, that's about Rs 1,500 in gains. But stock targets are never guarantees; they're educated guesses. Markets can change fast, so never invest money you aren't prepared to lose.
When is the best time to enter Zydus Lifesciences or Solar Industries shares?
Here's what you need to know: watch for Nifty breaking above 23,800 with strong volume. That breakout, if it happens, would be a strong confirmation signal. Many traders also suggest splitting your purchase into two parts—half now and half on a small dip—to reduce your timing risk and get a better average price.
